Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Frame of reference??
Just a reminder, if you are anyone you know is heading to Walmart, please keep in mind to check that out too!
It just occurred to me that although the copy I ordered online is not in stock, it might be available in the stores.
Walmart is much more important than Harps in the grander scheme of things, so I'm really hoping no issues there...
HAh ... I hate to say that previously I had never heard of them ... if the video is good, perhaps I'll become a fan!!
I ordered the Razorbacks DVD at Walmart a while back and it has not shipped yet despite being slated for last week. Thank goodness Walmart is not the only 15% vendor so any issues there will not be catastrophic... killed them on TITA but hopefully this is not an ongoing issue like they say.
The odd part is that it was available for order so its not that they were just making stuff up... perhaps just delayed a bit. Worst case scenario is that the Walmart order was cancelled so the DVD's were sent to Harps instead (perhaps at a discount for Harps?). Just my crazy imagination perhaps...
Have not seen anything at Walmart since Turtles and Deceptz.
(Of course there is now Netflix and Redbox, which -- as a worst case scenario -- is compensation.)
I certainly don't see the company going bankrupt or any massive dilution, so I'm ok waiting for the audit ...
As you say, the shareprice/marketcap is very low so other than these two circumstances, I'm quite happy to accumulate as it's priced for these events! Lots of positives recently, which does not hurt either!
I've answered your questions so how about you answer mine... what are your revenue forecasts for all the upcoming releases?
I had a feeling we might drop too ... folks are way to impatient with this company. Bought some more at .0168!!
HHSE - snagged some at .0168 ... I'm back to the same levels as before then big run ... we'll see what happens...
Good acting and some depressing insights into the dark side of human nature. Unlike most other movies, the antogonist was "evil" in a way that was very convicing and real.
I generally like other types of movies, though ... it was not a 'plot twist' type movie but more or a pure drama.
Thanks for remembering ... very nice to see!!
Watched Cook County on VODWIZ and it worked perfectly...
The webpage itself could be designed better, but we are such a small company its unfair to compare to other corporate sites.
Sort of like Scottrade webpage .. not the best design and interface, but cheap, functional, meets the essential needs.
Ouch ... not day of the stills today!
Courtpuppy - as you seem to have some very strong opinions, let's be a little more scientific about this. What are anticipated revenue projections for say -- the next 1 or 2 quarters?
It would be intersting to know this by each of the main releases ... if you were not aware of all the releases please ask and we can provide them for you.
Don't forget SeaWorld liked Turtle enough to feature it at their park!
ORT/EORBF - getting killed recently due to delays in getting financing for their calcinator ....
I'm taking a BIG risk posting this here as this news is seemingly not for US consumpiton ... don't tell anyone else!
http://finance.yahoo.com/news/orbite-updates-status-offering-210100242.html
MONTREAL, QUEBEC--(Marketwired - Aug. 14, 2013) -
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Orbite Aluminae Inc. (ORT.TO)(EORBF) ("Orbite"), further to its press release dated July 25, 2013, wishes to update the market on its financing initiatives. Orbite management confirms its commitment to completing an equity offering within the coming weeks. The Corporation is currently reviewing a number of financing options, including the reassessment of the terms of the offering provided in the Corporation's prospectus dated July 15, 2013 following recent stock price variations. "We are committed to our primary objective of completing construction and optimization of our HPA production facility and are confident about completing an equity financing that will raise at least a significant portion of the funds required to that end," said Glenn Kelly, Orbite's Chief Operating Officer.
This release does not constitute an offer for sale of securities nor a solicitation for offers to buy any securities. The securities referred to in this press release have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. persons", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Got it ... thanks! Looks good!
(I had to reset my password so I was having some issues ....)
Isn't vodwiz setup only for Roku? How did you watch on your phone?
She's definately coming back to life!! I did not have funds to buy at the lower levels, but I have not sold a single share either so its very nice to see the recovery!
XIN rocking! A nice double for me but still only a PE of 3. ... still lots of room left to increase while I collect the 3% dividend and funds from covered calls (which are very nice premiums).
HHSE - I can confirm Zombie Warz is indeed available at a local Redbox (in Florida).
I was surprised it is on the main screen alongside 'Olympus has Fallen'.
HHSE - well, I think my prediction was that it would not drop below 1.8... it pierced that today so I was wrong there!
Hopefully, I'm right about the longer-term. They've strongly committed themselves to the audit, so that is certainly going to weigh the price down but also there is, obviously, lots of potential if the audit is indeed released.
I'm excited to see the partner movies announced/released to VODWIZ. If/when it happens that will bode very well for the longer-term. Also, if NTEK Nuvola is announced by a major retailer (Amazon does not count as anyone can sell there) or is independently confirmed to function well, then that will be a major positive in removing doubt ... if Nuvola is legit so also is VODWIZ.
For better or worse, we should soon have a clearer idea.
If audit and VODWIZ fail then John Lennon, Zombie Wars and College Football, etc. will justify holding longer term as these things certainly have some value ... the shareprice, of course, will certainly take a beating in the near term so it will be a very rough (and depressing) ride.
Let's see what happens...
I agree ... huge potential indeed!
I'm just curious why someone so extremely pessimistic would continue to hold for months and years? Perhaps, despite all the complaints, he sees the same potential??
Hi Malc - I was waiting for a bit bigger dip on IRE.. my greed got the best of me! I'm still with you on SAN.
Greed got the best of me on INO too ... should have sold a bit more aggressively, but I also got sucked in to those Merck rumors! I'm in for the longer term, though, as there remains tons of potential. If it runs before any subtancial news again, I'll be sure to unload a bit more...
Glad I'm out of CNYD ... I pitty the fool who bought my shares, though.
Shhh .. just let the company keep buying back cheap shares ... at this rate, eventually you and I will own the whole company!
Imagine the dividend THEN ... lol!
Give me a break ... I'm trying to do this at work and that PR wasn't even out when Michael provided that number ... It's not in the MD&A.
But yes, 18M is certainly not too bad if it's the end ... thanks for pointing that out.
Interestingly, at the current share price the 95M would cover all the long-term debts (which are about $2.1M). So perhaps the 'worst-case' potential dilution over time remains 95M. That's also not catastophic, but the worst case seems always to be the norm which I'm hoping we soon break out of!
ok ... thanks (just wanted to be sure.)
HHSE - Michael, on the other board you had posted there are 50 million potential new shares...
My understanding is that the potential is 95 million new shares based on the 505 million current shares in issue as noted below:
http://www.otcmarkets.com/financialReportViewer?symbol=HHSE&id=107176
I'm probably missing something but wanted to double-check...
If anyone else can confirm, I'd appreaciate it...
CNYD - 11.75 Damn! Well, 9.50 is double what I could have got any time over the last year... so I should be glad.
CNYD - Sold @ 9.50!
CNYD - back from the dead??? This is crazy to say, but I'm down *only* 80%!
XIN +10% PM - Q2 filing beating guidance...
http://ih.advfn.com/p.php?pid=nmona&article=58734793&symbol=XIN
BEIJING, Aug. 8, 2013 /PRNewswire/ -- Xinyuan Real Estate Co., Ltd. ("Xinyuan" or "the Company") (NYSE: XIN), a residential real estate developer with primary focus on high growth cities in China, today announced its unaudited financial results for the second quarter of 2013.
Highlights for the Second Quarter 2013
•Total second quarter revenues were US$198.5 million, a 17.2% increase from US$169.4 million recorded in the first quarter of 2013 and a 21.6% decrease from US$253.1 million reported in the second quarter of 2012. Second quarter revenue exceeded the previous guidance of US$140.0 million by 41.8%.
•Contract sales totaled US$196.0 million, a 9.9% increase from US$178.3 million recorded in the first quarter of 2013 and a 24.0% decrease from US$258.0 million recorded in the second quarter of 2012. Second quarter contract sales exceeded previous guidance of US$150.0 million by 30.7%.
•Total gross floor area ("GFA") sales were 147,200 square meters, an 18.1% increase from 124,600 square meters sold in the first quarter of 2013, and a 24.3% decrease from 194,500 square meters sold in the second quarter of 2012.
•Selling, General, and Administrative ("SG&A") expenses as a percent of total revenue totaled 7.4% compared to 7.3% in the first quarter of 2013 and 6.2% in the second quarter of 2012.
•Net income reached US$39.4 million, a 48.1% increase from US$26.6 million in the first quarter of 2013 and a 43.2% decrease from US$69.4 million reported in the second quarter of 2012. Second quarter net income exceeded the previous guidance of US$25.0 million by 57.6%.
•Diluted net earnings per American Depositary Share ("ADS") attributable to shareholders were US$0.54, compared to diluted net earnings per ADS of US$0.37 in the first quarter of 2013 and US$0.94 per ADS in the second quarter of 2012.
•Cash and cash equivalents, including restricted cash, increased by US$248.3 million from US$626.4 million as of March 31, 2013 to US$874.7 million as of June 30, 2013. Short and long term debt increased by US$194.6 million from US$316.1 million as of March 31, 2013 to US$510.7 million as of June 30, 2013.
•Book value increased to US$850.8 million, or US$11.94 per ADS, as of June 30, 2013 compared to US$807.9 million, or US$11.37 per ADS, in the first quarter of 2013 and US$719.2 million, or US$9.86 per ADS, as of June 30, 2012.
•The Board of Directors of the Company has approved the payment of a quarterly dividend of US$0.05 per ADS payable on August 30, 2013 to shareholders of record on August 16, 2013.
Mr. Yong Zhang, Xinyuan's Chairman and Chief Executive Officer said, "We are very pleased with our operational and financial results in the second quarter, where we once again exceeded our contract sales, revenue and net income forecasts. The stronger-than-expected results demonstrated our ability to achieve and surpass corporate objectives and financial targets. The fundamentals of China's housing market remained healthy in the second quarter and buying demand at our development projects remained strong, improving our sequential quarterly revenue growth and profitability."
"Looking at the second half of this year, we expect to continue developing projects at a measured pace with stable average selling prices. Sellable inventory levels further decreased in the second quarter, however, we expect sales to accelerate as four new projects commence pre-sales in the -second half of the year. Consequently, we are once again raising our full year 2013 financial forecast."
"In the second quarter of 2013, Xinyuan purchased 1,314,858 ADS on the open market at a total cost of approximately US$5.77 million. Our Board recently approved an additional US$60 million share repurchase program through 2015, as well as a second quarterly cash dividend payment for 2013 of $0.05 per ADS. The existing share repurchase program combined with our regular dividend demonstrates our confidence in Xinyuan's long-term growth prospects."
Financial Results for the Second Quarter 2013
Contract Sales
Contract sales totaled US$196.0 million in the second quarter compared to US$178.3 million in the first quarter of 2013 and US$258.0 million in the second quarter of 2012. The Company's GFA sales were 147,200 square meters in the second quarter of 2013 versus 124,600 square meters in the first quarter of 2013 and 194,500 square meters in the second quarter of 2012. The average selling price per square meter sold was RMB8,312 (US$1,332) in the second quarter of 2013 versus RMB8,985 (US$1,431) in the first quarter of 2013 and RMB8,367 (US$1,326) in the second quarter of 2012. Second quarter contract sales included a US$43.2 million contractual government facility sale to Jinan municipal authorities as required per the original land bidding documents of nearly 46,600 square meters at a price of RMB5,789 (US$927) per square meter.
Breakdown of GFA Sales and ASP's by Project
Revenue [see link]
In the second quarter of 2013, the Company's total revenue was US$198.5 million compared to US$169.4 million in the first quarter of 2013 and US$253.1 million in the second quarter of 2012.
Gross Profit
Gross profit for the second quarter of 2013 was US$69.9 million, or 35.2% of revenue, compared to a gross profit of US$55.7 million, or 32.9% of revenue, in the first quarter of 2013 and a gross profit of US$77.5 million, or 30.6% of revenue, in the second quarter of 2012.
The improvement of gross profit as a percentage of revenue over previous periods was largely due to lower total project cost estimates on the Company's Chengdu Splendid II, Kunshan International City Garden, and Zhengzhou Modern City projects. These mature projects are near completion, and the Company has reached favorable settlements with contractors. The Company also increased total project revenue estimates on the Jinan Xinyuan Splendid and Zhengzhou Century East A & B projects to reflect higher than expected selling prices in recent quarters.
Selling, General and Administrative Expenses
SG&A expenses were US$14.7 million for the second quarter of 2013 compared to US$12.4 million for the first quarter of 2013 and US$15.8 million for the second quarter of 2012. As a percentage of total revenue, SG&A expenses were 7.4% compared to 7.3% in the first quarter of 2013 and 6.2% in the second quarter of 2012.
Net Income
Net income for the second quarter of 2013 was US$39.4 million compared to US$26.6 million for the first quarter of 2013 and US$69.4 million for the same period in 2012. Net margin was 19.8%, compared to 15.7% in the first quarter of 2013 and 27.4% in the second quarter of 2012. Diluted earnings per ADS were US$0.54, compared to US$0.37 per ADS in the first quarter of 2013 and to US$0.94 per ADS in the same period in 2012. Second quarter 2013 net income included a US$9.0 million income tax benefit realized on the expiration of a five year statute of limitations period.
Balance Sheet
As of June 30, 2013, the Company reported US$874.7 million in cash and cash equivalents (including restricted cash) compared to US$626.4 million as of March 31, 2013 mainly from the Company's newly issued US$200 million bond proceeds. Total debt outstanding was US$510.7 million, an increase of US$194.6 million compared to US$316.1 million at the end of the first quarter of 2013. The value of the Company's real estate property under development at the end of the second quarter was US$605.7 million compared to US$620.2 million at the end of the first quarter of 2013.
Project Status
Below is a summary table of projects that were active in the second quarter of 2013.
[see link for table]
As of June 30, 2013, the Company's total sellable GFA was approximately 884,100 square meters for active projects and pre-revenue stage projects. Below is a summary of all projects at Xinyuan that are in the planning stage:
Unsold GFA
(m2 000)
Pre sales
Scheduled
Newly Acquired Zhengzhou Land
(Zhengzhou XIN City)
207.4
Q3 2013
Newly Acquired Xuzhou Land
(Xuzhou Colorful City)
117.5
Q4 2013
Newly Acquired Suzhou Land
(Suzhou XIN City)
126.3
Q3 2013
Newly Acquired Beijing Land
(Beijing Xindo Park)
117.7
Q4 2013
Newly Acquired New York Land
37.1
Total projects under planning
606.0
Total active projects
278.1
Total all Xinyuan projects
884.1
Third Quarter and Full Year 2013 Outlook
The Company projects higher sequential results in the third quarter of 2013 based on launch of presales activity on two new projects: Zhengzhou XIN City and Suzhou XIN City.
The Company expects third quarter contract sales to reach approximately US$200 to US$220 million. Third quarter revenue is expected to total US$210 to US220 million while net income is projected at US$25 to US$30 million.
With the fourth quarter addition of Xuzhou Colorful City and Beijing Xindo Park to the Company's active project list, the Company has raised its full year 2013 financial forecast.
Contract sales for the full year 2013 are expected to exceed US$880 million. Revenue under the percentage of completion method is expected to exceed US$820 million while net income is expected to exceed US$110 million for the year.
Conference Call Information
Xinyuan's management will host an earnings conference call on August 8th at 8:00 a.m. U.S. Eastern Time. Listeners may access the call by dialing 1-719-325-2448. A webcast will also be available through the Company's investor relations website at http://www.xyre.com. Listeners may access the replay by dialing 1-858-384-5517, access code: 7709905
Thanks once again for the thoughts ... just soooo frustrating that things seem to really be turning around (compared to a few months ago) and we get hit with this!
I'm still trying to get my head around a reasonable worst-case scenario ... bankruptcy certainly does not seem pending, and neither does significant dilution (with the authorized share reduction). With all the hard work (such as Eric's wife's contribution to TITA)... I certainly get the feeling they are trying very hard to make things work so I don't see outright fraud either. But with the lack of audit, am I naïve of some scheme to deceive shareholders?
Very frustrating that when I weigh the potential upside and downside, the downside scenario seems always to happen. Fortunately, the downside has not been catastrophic but, for years, significant progress has seemed just around the corner...
Fortunately also, with such extremely low marketcap, disappointments are more than priced into the stock so I'm not selling now ... I think we are soon due for some better luck so let's see....
(OK, that's off my chest ... I feel better now!)
What's your take POS? ... of course, the shareprice is not going to react well, but what do you think in terms of the longer-term outlook of this business ... say two years from now? If you are more into the shorter-term, that's fine, but that's where I'm focused.
There is such a mixture of positives and negatives, my head is going to explode!
I've always been concerned about Toys in the Attic not being at Walmart ... there has not been much foundation for earnings in recent months. Thus with debts coming due, there certainly could be cash short flows despite the many upcoming releases.
As a more pessimistic interpretation, there is outright fraud where the company is worth much less the current marketcap and unaudited financials have stated. Could be ... that would explain why they keep promising the audit, but then why such little dilution so far, Eric's wife putting a lot of work into Toys in the Attic... etc. How have they remained solvent?
I'm trying to get my head around reasonable optimistic and pessimistic scenarios and nothing really makes sense! I've not mentioned NTEK which is a whole other level.
But yes, it really sucks that they have not released the audit. I'm appreciate genuine discussion and nuanced discussion (weighing both positives and negatives) that certainly does not exist on the other board!
VRS "Verisante Technology, Inc. Announces Study on Nasopharnygeal Cancer in China"
Gosh I wish I had funds to buy at the open (like I was thinking yesterday). The Canadian ticker is up 17%....
http://finance.yahoo.com/news/verisante-technology-inc-announces-study-140000315.html
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug 7, 2013) - Verisante Technology, Inc. (TSX VENTURE:VRS) (VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Fujian Normal University in China (the "University") to develop a new application for the Company's exclusively licensed platform technology.
Verisante has currently licensed technology from the BC Cancer Agency to develop its Coreâ„¢ devices, which use an endoscope for the detection of lung, colon, gastro-intestinal and cervical cancers. This new collaboration adds an option to include nasopharyngeal cancer on the list of applications licensed from the BC Cancer Agency to Verisante. The University will be using a nasopharyngeal endoscopic laser Raman system in a study to detect cancerous lesions. Verisante is providing the University with a ClearVu Elite fluorescence endoscopy system. Dr. Haishan Zeng, a distinguished scientist in the Integrative Oncology Department at BC Cancer Agency is leading the development of a nasopharyngeal endoscopic Raman probe. Both the fluorescence imaging system and the Raman spectroscopy probe will be used in the detection and analysis of spectral data collected on patients in China at the Fujian Provincial Tumor Hospital.
"The Verisante Coreâ„¢ for nasopharyngeal cancer detection has the potential to significantly improve patient outcomes," said Dr. Zeng, who is also an associate professor of dermatology and skin science at the University of British Columbia in addition to his work at the BC Cancer Agency. "Our collaboration with the Fujian Normal University in China is an important step in testing the technology on real patients in a clinical setting."
Nasopharyngeal carcinoma is the most common cancer found in the nasopharynx (the upper part of the throat behind the nose). It is fairly rare in North America, but much more common in Southern China and North Africa and was the seventh most fatal cancer in Hong Kong in 2011. The five-year survival rate for people diagnosed with nasopharyngeal cancer is 72 per cent if found early, decreasing to only 38 per cent if found at a later stage.
"We are pleased to continue our partnership with the BC Cancer Agency and to collaborate with a reputed research organization like Fujian Normal University in China," said Thomas Braun, President and CEO. "While the Company continues to work closely with our exclusive distributors to support sales and marketing efforts of our skin cancer detection device, Auraâ„¢, we are also making good progress with Verisante Coreâ„¢. Adding the nasopharyngeal application and collaboration with China nicely rounds out our continuing portfolio of studies on applications for the Coreâ„¢, which will be our next product to market. There continues to be high level interest in developing applications for the Coreâ„¢ in China and throughout the Asian markets."
In addition to this new nasopharyngeal collaboration, the clinical studies involving lung cancer and colon cancer using Verisante Coreâ„¢, the Company's endoscopic Raman technology, continue.
Lung Cancer
The lung cancer clinical trials conducted at the BC Cancer Agency and led by Dr. Stephen Lam have now been concluded and the statistical analysis of the results is underway. Raman spectra have been collected from more than 300 malignant and benign lesions.
The current study builds on the initial success of the pilot study using an improved Raman system. The pilot study was able to obtain clear in vivo Raman spectra in one second and pre-neoplastic lesions were detected with a sensitivity of 96 per cent and a specificity of 91 per cent.
Colon Cancer
A colonoscopy Raman probe has been successfully developed by Dr. Zeng's team at the BC Cancer Agency. A clinical study led by Dr. Isabella Tai is now being conducted at Vancouver General Hospital in British Columbia, Canada. So far, measurements on two patients have confirmed the functionality of the probe and the quality of the acquired Raman spectra.
Colon cancer is the second-leading cause of cancer death in Canada and the third most common cancer in the United States as well as the second leading cancer killer. Every year in the United States there are more than 100,000 new cases of colon cancer diagnosed.
Some folks were really pessimistic that these two things would not come to fruition ...you'd think they'd acknowledge the good progress and perhaps even appologize for stirring up what has turned out to be needless concern.
Guess there are some folks you just can't please!
Do you think the numbers include Safeway? ... that is a huge account that still might be coming. I've not seen any photos at Safeway and they don't exist in my state so I'm not sure... it would seem not due to the normal lag but some here have posted seeing it there.
http://www.pulsebeverage.com/news/news_releases/2013/04/pulse-secures-cabanatm-national-listing-for-safeway-inc
Anyone shop at Safeway? ... I'd be very greatful if you could check for Cabana Lemonade!
Folks on the PLSB board have supposedly spotted Cabana there, but as nobody has posted a photo, I'm skeptical ... it is supposed to take 4 months for a new listing to have sales (which would provide room for further growth.)
PLSB Q2 2013 - behind a bit on their goal for 1 million annualized case sales (126K in Q2 X 4 = 504K annualized), with 63% growth in the quarter, I'm happy with the progress. Also, Safeway was announced just a couple of months ago, so I'm not certain those sales are included.
http://ih.advfn.com/p.php?pid=nmona&article=58717766&symbol=PLSB
http://biz.yahoo.com/e/130806/plsb10-q.html
The Pulse Beverage Corporation (OTCQB: PLSB) ("Pulse"), makers of PULSE® brand of functional beverages and Natural Cabana® Lemonade, today announce its second quarter financial results for 2013 ("Q2-2013") and issued a corporate update.
Gross revenues for Q2-2013 increased 63% compared with Q1-2013 and 48% when compared to Q2-2012.
Gross profits for Q2-2013 were 38% compared to 32% for Q1-2013 and 35% for Q2-2012. This improvement in cost of sales and gross profit is due to higher production volumes and better efficiencies at our co-packers.
For Q2-2013 Pulse's net loss after adjustments to bring generally accepted accounting principles (GAAP) to adjusted net loss before corporation income taxes, depreciation and amortization and stock based compensation was $437,000 (Q2-2012 - $327,000). This loss was, for the most part, an investment in the establishment of our extensive distribution system. This loss is minimal considering that Pulse has only been in commercial operations, since the launch of Natural Cabana® Lemonade, for some twenty-one months. Most emerging growth beverage companies incur significantly larger losses in the first few years of operations after commencing product launches and do not reach the one million annual case sale level until the fourth or fifth year after product launch; Pulse expects its Natural Cabana® brand to reach the annualized one million cases threshold by the end of 2013.
INO - down 25% ... still very happy overall but my lucky trading streak might have come to an end!
Hopefully, if Merck partnership/buyout rumors don't come to frution we don't drift back down to 65 cents!
That's what I like about your thinking Harleyman! ... you are able to separate your assessment of the business from the recent trading trends.
VRS - I have not sold a share, but have not yet had the courage to buy more ... I've been certainly thinking about it though, this is how big $$$ is made!
Yes, things are progressing a bit slowly, but I don't see any major set backs ... I'm sure much of the shareprice decline isn't that the potential is so much worse, rather investors are just getting impatient. Reminds me a bit of the trading of WNDEF... it had a quiet period and just kept dropping.
I think I just talked myself into picking up more shares ... if I didn't have so many already it would be an easier decision!